A prospective randomized trial comparing patent blue and methylene blue for the detection of the sentinel lymph node in breast cancer patients

A prospective randomized trial comparing patent blue and methylene blue for the detection of the sentinel lymph node in breast cancer patients

Summary Introduction: Methylene blue is more widely available and less expensive than patent blue, with an apparently lower risk of anaphylaxis. Objective: The two dyes were compared regarding detection of the sentinel lymph node (SLN). Method: A prospective, randomized trial involved 142 patient...

Full description

Bibliographic Details
Main Authors: Régis Resende Paulinelli, Ruffo Freitas-Junior, Rosemar Macedo de Souza Rahal, Luis Fernando de Pádua Oliveira, Maria Helena Tavares Vilela, Marise Amaral Rebouças Moreira, Katyane Larissa Alves, Marina Berquó Peleja, Tatiane Coelho Capel de Resende
Format: Article
Language:English
Published: Associação Médica Brasileira
Series:Revista da Associação Médica Brasileira
Subjects:
câncer de mama
linfonodo sentinela
azul patente
azul de metileno
ensaio clínico randomizado
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302017000200118&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302017000200118&lng=en&tlng=en

Similar Items